This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...

A GROUNDBREAKING study has revealed how the human immune system evolves across the lifespan, uncovering age-specific changes ...

Aging reshapes breast tissue, boosting cancer risk via epigenetic and immune shifts. Key insights for clinical practice.

A person with neuroblastoma, which occurs when developing nerve cells in children turn cancerous, has remained tumour-free ...

Developing effective treatments and understanding how the mechanism of the immune system have always been challenging for ...

Clinical Director Dr Robert Weinkove says ‘site activation’ in Christchurch and Auckland marks a significant milestone for the clinical trial, and means more patients can be treated, closer to home.

An 18-year survivor of neuroblastoma, a solid childhood tumor that develops in immature nerve cells, is believed to represent ...

CAR T-cell therapies have demonstrated efficacy in treating blood cancers but, so far, their safety and effectiveness in ...

During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...

The FIRCE-1 trial investigating the CAR T-cell therapy firi-cel in relapsed/refractory large B-cell lymphoma has been ...